Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early deathEli Muchtar, Angela Dispenzieri, Steven R. Zeldenrust et al.|Blood|2017Cited by 340
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteriaArjun Lakshman, Shaji Kumar, S. Vincent Rajkumar et al.|Blood Cancer Journal|2018Cited by 288
Trends in survival of patients with primary plasma cell leukemia: a population-based analysisWilson I. Gonsalves, Shaji Kumar, S. Vincent Rajkumar et al.|Blood|2014Cited by 139
Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myelomaCharalampos Charalampous, Shaji Kumar, Utkarsh Goel et al.|Blood Advances|2022Cited by 26
OAB-052: Impact of chromosome 1 abnormalities on newly diagnosed multiple myeloma treated with proteasome inhibitor, immunomodulatory drug, and dexamethasone: analysis from the ENDURANCE ECOG-ACRIN E1A11 trialPrashant Kapoor, Shaji Kumar, Timothy M. Schmidt et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 16